Table1. Clinicopathological features of each group in the original and propensity score-matched cohort.
Original cohort | Propensity score-matched cohort | |||||||
BLI group | NBI group | P value | SD | BLI group | NBI group | P value | SD | |
Lesions | 499 | 1459 | – | – | 471 | 471 | – | – |
Macroscopic type, number (%) | ||||||||
|
321 (64.5) | 843 (57.8) | 0.011 | 0.049 | 299 (63.5) | 293 (62.2) | 0.736 | 0.01 |
|
178 (35.5) | 616 (42.2) | 172 (36.5) | 178 (37.8) | ||||
|
7.9 ± 9.02 | 10.2 ± 11.3 | < 0.001 | 0.23 | 7.97 ± 9.14 | 7.91 ± 9.56 | 0.92 | 0.006 |
Lesion location, number (%) | ||||||||
|
279 (55.9) | 844 (57.8) | 0.482 | 0.014 | 277 (58.8) | 272 (57.7) | 0.792 | 0.008 |
|
163 (32.7) | 472 (32.4) | 0.941 | 0.002 | 154 (32.7) | 157 (33.3) | 0.89 | 0.005 |
|
57 (11.4) | 143 (9.8) | 0.344 | 0.018 | 40 (8.5) | 42 (8.9) | 0.908 | 0.005 |
Histological findings, number (%) | ||||||||
|
65 (13.0) | 103 (7.1) | < 0.001 | 0.86 | 42 (8.9) | 39 (8.3) | 0.816 | 0.008 |
|
394 (78.9) | 1111 (76.1) | 0.23 | 0.03 | 389 (82.6) | 396 (84.1) | 0.6 | 0.014 |
|
21 (4.1) | 90 (6.2) | 0.14 | 0.034 | 21 (4.5) | 17 (3.6) | 0.62 | 0.016 |
|
3 (0.5) | 27 (1.9) | 0.079 | 0.046 | 3 (0.6) | 2 (0.4) | 1 | 0.01 |
|
16 (3.6) | 128 (8.8) | < 0.001 | 0.077 | 16 (3.4) | 17 (3.6) | 1 | 0.004 |
HP, hyperplastic polyp; SSL, sessile serrated lesion; LGD, low-grade dysplasia; HG, high-grade dysplasia.